chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Experienced chest that radiated into my arm and jaw. I was taken to the hospital and told I had an NSTEMI. I was taken to the cath lab and had 1 stent placed in my RCA. A plaque had ruptured and caused a 90% occlusion. I was sent home the next day.  My pregnancy was normal except that I am high risk and developed hypertension prior to becoming pregnant. I was induced at 37 weeks due to my blood pressure becoming getting higher. During my induction, I received magnesium infusion and an epidural. I gave birth. I was then hospitalized fora  post partum hemorrhage on 11/21/2021 and discharged the next day. While I was home, I found that I felt poorly and was exhausted. On 12/02/21 I went to the hospital with chest pain that radiated to my back and jaw and was admitted for anemia that required a blood transfusion. I was admitted until 12/7/21.
Immediate burning in my arm as the vaccine was injected. Soreness in my arm there after. In the next 24 hours I had trouble concentrating and remembering anything. I felt like I had pregnancy brain. This lasted for almost 5 days. I woke up and found my ear had started bleeding at some point. Sever headache and nauseous for the next 2 days.
Acute stiff neck with significant decreased range of motion and sharp pain lasting 3 days. Symptoms  slowly subsided over course of one week. Patient is still experiencing pain in shoulder (upper trapezius) 6 months later. Patient did not experience this pain before second dose of covid vaccine.
Left upper arm elbow to shoulder, red hot, onset today approx. 12:00 pm. Tx cold follwed by warm moist pcaks, Benedryal.
Pain at injection spot black and blue at sight. 2 months - Hospital X Ray pain pills administered 10-14-15 AM. Still in pain 12-19-15.
Within 24 hours arm was itching, 48 hours post vaccination arm was hot to touch, swollen and red.
Headache; Arm tenderness; Nausea; Chills; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE, VACCINATION SITE PAIN, NAUSEA, and CHILLS in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced HEADACHE, VACCINATION SITE PAIN, NAUSEA, and CHILLS. At the time of the report, HEADACHE, VACCINATION SITE PAIN, NAUSEA, and CHILLS outcome was unknown. Not Provided.       The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
Burning eyes, headache for 3 days, joint ache, body ache, ear ache, gum ache. Weak shaky pt was sleeping for 5 days. Cannot keep eye open, fever, no stomach ache. No vomiting, loose stool but no diarrhea. Pt had no treatment.
at a low of negative 5.1C out of range for 12 minutes and a low of 1.3C out of range for 10 minute with no adverse event; administering dose post temperature excursion with no reported adverse event; Initial information received on 06-Sep-2022 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 23 years old female patient who reported administering dose post temperature excursion with no reported adverse event and at a low of negative 5.1c out of range for 12 minutes and a low of 1.3c out of range for 10 minute with no adverse event while receiving vaccine DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL].   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.    On 31-Aug-2022, the patient received a  0.5 ml dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE once (1X) ( lot U7461AA; expiry date: 12-JUL-2024) via intramuscular route in the right arm for immunization.  On 31-AUG-2022 the patient reported a non-serious event administering dose post temperature excursion with no reported adverse event (poor quality product administered) following the administration of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE. On an unknown date the patient developed a non-serious at a low of negative 5.1c out of range for 12 minutes and a low of 1.3c out of range for 10 minute with no adverse event (product storage error) (unknown latency) following the administration of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE.  Action taken: not applicable.   At time of reporting, the outcome was Unknown for the events.    This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments:  01266747: 01266903: 01266768: 01266921: 01266924: 01266780: 01266792: 01266974: 01266976: 01266978: 01266980: 01266982: 01266983: 01266985: US-SA-2022SA372080:
When patient came home after having the H1N1 flu mist at school he had hives all over his body. His mother phoned their doctor and was instructed to administer Benadryl.  By Sunday, hives was not improving so they went to an urgent care where Hydralazine was prescribed and as of Monday patient was improving.
Information has been received from a health professional concerning an 11 year old female with a history of a "reaction" to AMOXIL, who on 12-FEB-1997 was vaccinated with a dose of Varivax. On 20-JUN-2006 the patient developed chicken pox and had "20-25 lesions) on her neck, shoulders, chest and legs. No fever or itching was noted. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information from the registered nurse indicated that the patient had recovered. No additional information was available. The vaccination was not given at that office. No further information is expected.
started itching on arms & neck-chills & hot; throat started hurting; arm was swollen hot & a large firm area; aches a lot & tender & touched rash on neck & arms felt dizzy;
26 year old male patient, without chronic health conditions, does not refer use of medications. 5 minutes after vaccination with the Janssen vaccine, refers to being dizzy so that paramedics lays him down on the floor presenting a vasovagal episode. At the estimated time he ceases the flow, he verbalizes he use medical marijuana. He is placed in a position with feet elevated. Paramedic takes S/f 09/08 the patient eats a muffin and drinks a coco cola. He is placed on a stretcher and is observed for 30 minutes. Then he stabilized and is discharged. He is oriented to hydrate well and rest. Retires 2:45 pm.
On day 8, area below injection site was  erythemic , edematous and pruritus (approx 10cm in diameter).
Site: Redness at Injection Site-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Flushed / Sweating-Mild, Additional Details: Administed vaccine, pt stated she felt she would pass out. I told her to take a couple of deep inhalations.  I took her temp 95.5F She laid on the floor said she was starting to feel better, got up and sat in chair. Afew minutes later said she felt faint again and laid on floor. I call 911, she said she did not want to see any responders, said she was going home, got up and left. would not wait for card, did not want any treatment -just left .  I called and cancelled the 911 call
Soon after injection I developed soreness at injection site, and about an hour later it travelled down my arm and to my hand, with also arm stiffness.  On Monday, 4/12/2021 at 12:15am (about 6 hours after injection) I developed chills and body aches.  Throughout the night I also developed a headache, muscle aches, nausea and started sweating.  At 9am (4/12/2021) when I woke up, all the symptoms continued (chills, body aches, muscle aches, arm soreness and stiffness, headache, nausea) and also felt extreme tiredness.  My temperature at 9:15am was 100.4 degrees F.  I basically stayed in bed and slept most of the day.  I got up at 2:30pm to get something to eat and had a temperature of 101 degrees F.  After eating, which made me feel even more nauseous, I went back to bed and continued to sleep.  I woke up at 7:30pm to feed the cats.  I felt the same as I did at 2:30pm--listed above--and was up and about for 20 minutes.  I started to prepare a quick meal and fainted twice (around 8pm) within a minute from each other.  The first time I fell to my knees and the second time I felt onto my back.  I was unconscious for only a few seconds each time.  I went into bed after and placed an ice pack on my forehead.  I took my temperature after the ice pack at 8:15am and my temperature was 101.4 degrees F.   I ate soup around 8:45am and took Tylenol (1000mg) at 9:30am.  I went back to bed and slept all through the night.  This morning (4/13/2021--2 days after injection) I feel much better--only have some slight chills and arm soreness.  My temperature at 9:15am (4/13/21) was 95.7 degrees F.
No adverse effects.  Patient was given pediatric dose with no diluent instead of the adult dose.  No reported issues
sleeping non stop; same pain at injection site of her left arm lasting 24-48 hours after second dose; extreme fatigue since the 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSOMNIA (sleeping non stop), VACCINATION SITE PAIN (same pain at injection site of her left arm lasting 24-48 hours after second dose) and FATIGUE (extreme fatigue since the 2nd dose) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included FLUOXETINE, PROPRANOLOL, TRAZODONE, ACETIC ACID, TRETINOIN, MULTIVITAMIN [VITAMINS NOS], VITAMIN D NOS, CLINDAMYCIN and SULFAMETHOXAZOLE for an unknown indication.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Apr-2021, the patient experienced HYPERSOMNIA (sleeping non stop), VACCINATION SITE PAIN (same pain at injection site of her left arm lasting 24-48 hours after second dose) and FATIGUE (extreme fatigue since the 2nd dose). At the time of the report, HYPERSOMNIA (sleeping non stop), VACCINATION SITE PAIN (same pain at injection site of her left arm lasting 24-48 hours after second dose) and FATIGUE (extreme fatigue since the 2nd dose) outcome was unknown.            Treatment medication was not provided.   This case was linked to MOD-2021-106727 (Patient Link).
swelling and rash (R) thigh 2 days after injection been same status since as days post Rxn. Reaction began 1 day after administration
Four hours after vaccine administration , patient started to experience arm soreness, shortness or breath, dizziness, facial numbness, and anxiousness.   Patient is to have eaten an estimated 500 calories since 6am in the morning.   After providing food, water, Gatorade and ice pack she improved.
Chest pains right in the center of my sternum.  Happened while driving, then again a couple days later while trying to go to sleep and once while sitting in a chair
Initial report received from a non-healthcare professional via other company (Merck national service center) on 14 March 2014. A male patient, whose age, medical history and concomitant medications were not reported, had received a dose of Tetanus vaccine (lot number, dose number and site of administration were not reported) on an unspecified date. On an unspecified date after vaccination, the patient experienced an unspecified allergic reaction. laboratory data and corrective treatments were not reported. At the time of this report, the outcome was unknown. List of documents held by sender: none.
- Blood blisters in mouth the day after each vaccine shoot - Chills from 2nd vaccine shoot (02/26/21)  and still ongoing  (7/10/2021) - Vertigo started approximately on the 6/10/2021 and still ongoing (7/10/2021)
Full body hives - going on week 7. Antihistamines help keep the itching down, but skin is sensitive, red and blotchy still. Without antihistamines , hives will appear in large clusters , disappearing and reappearing in different locations all over body. Most common locations are neck, chest, face, ears, scalp and hands. Still occurs everywhere though.
Had dizzy spell day that lasted about 3-5 seconds; This is a spontaneous report received from a contactable consumer. A 74 years old female patient received the first dose of bnt162b2 (Pfizer COVID 19 vaccine, lot number: EW0153) via unspecified route of administration in left arm on 14Apr2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications was reported as no. The patient experienced dizziness on 15Apr2021 with outcome recovered on 15Apr2021. The day after she received the vaccine, she had dizzy spell day that lasted about 3-5 seconds.  She stated she also had an echocardiogram 15-20 minutes prior to receiving her first vaccine.    No follow-up attempts are needed. No further information is expected.
Pt had a syncopal episode following covid-19 vaccine. Pt states he has had similar episodes following needle injections. Pt was closely monitored for 30 min following syncopal event. Pt stated that he felt much better and was discharged home.
PT HAD AN ALLERGIC REACTION TO THE ADACEL (TDAP) VACCINATION THAT WAS ADMINISTERED TO HER. SHE REPORTED DIFFICULTY BREATHY AND DISORIENTATION.
Rash on bottom - 3 large red round areas & several small pimply marks.  The area is uncomfortable - it is hard to lay down or sit.  MD diagnosed as shingles.
I felt like I was getting a really bad cold - like a worse cold ever - runny nose and bad headache and my body aches; chills. My body aches were really bad. I was tired and wanted to just sleep - I was drained. I went to ER - they ran some tests and gave me IV fluids.  Tylenol and Ibuprofen - alternated for my  headache. It took me about a week and a half to get better.  A day or two after the shot, my breathing was good and it was better than it had every been and it is still better. I feel great! It had always been hard for me to take a deep breath but ever since then when I take a deep breath and I have expected it to not to come out good but it comes out good. Even through my COVID symptoms I experienced these better breathing symptoms.
I contracted COVID-19 1/2/22 with symptoms of fever 100, chills, fatigue, cough, body aches, shortness of breathe, chest tightness/pain, headache, sore throat, congestion. I was prescribed a Z-pack and antibiotics. It took me 4 weeks to fully recover.
I had No symptoms until that incident, I became dizzy and fell, and ended up ER, broken ankle . I never have beendizzy before.
Swelling at the injection site; Pain at the injection site; Tired for a day; The injection site on the left arm started swelling; Tender to touch; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swelling at the injection site), VACCINATION SITE PAIN (Pain at the injection site), FATIGUE (Tired for a day), VACCINATION SITE SWELLING (The injection site on the left arm started swelling) and VACCINATION SITE PAIN (Tender to touch) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (Swelling at the injection site), VACCINATION SITE PAIN (Pain at the injection site), FATIGUE (Tired for a day), VACCINATION SITE SWELLING (The injection site on the left arm started swelling) and VACCINATION SITE PAIN (Tender to touch). At the time of the report, VACCINATION SITE SWELLING (Swelling at the injection site), VACCINATION SITE PAIN (Pain at the injection site) and FATIGUE (Tired for a day) had resolved and VACCINATION SITE SWELLING (The injection site on the left arm started swelling) and VACCINATION SITE PAIN (Tender to touch) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.   Treatment information was not provided.  After vaccination Patient was tired and experienced swelling and pain at the injection site, after 2-3 days the patient felt fine and arm became normal. She reported that again after 10 days of vaccination, the injection site on the left arm started swelling and it is tender to touch.   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: No new information. Patient declined the consent for follow-up.
A report was received from a health care professional on 10/24/03 concerning 3 vaccinees of unknown gender less than 4 years of age who inadvertently received Fluvirin on an unspecified date. On an unspecified date 3 vaccinees less than 4 years of age inadvertently received Fluvirin. It was unknown at the time of the report whether or not the vaccinees had exhibited any signs or symptoms of an adverse reaction. There was insufficient information to determine the reporter's causality assessment. Update 11/24/03: Further information was received from a health care professional on 11/24/03 indicating that the vaccinee was a 3 year old male who inadvertently received 0.25ml Fluvirin vaccine on 11/3/03. On 11/3/03 the vaccinee inadvertently received Fluvirin. No adverse events were reported at the time of the report. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Information has been received from a physician via Company representative concerning to a patient of unknown age and gender. Concurrent and historical conditions were not reported. Concomitant therapies were not provided. On 25-NOV-2014, the patient was vaccinated with an improperly stored dose of GARDASIL (Lot No. K001631, exp. 06-NOV-2016) (dose and site not reported). On an unspecified dates, the GARDASIL vaccine had two temperature excursions: 24 and 48 hours respectively. The lowest recorded temperature was 34 (1.111111111 Celsius degrees). The highest recorded temperature was 47 (8.333333333 Celsius degrees). The vaccine status was reported as "in excursion". The vaccine storage criteria and the vaccine excursion were reported as "Refrigerator (R)". No adverse effects were reported. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
Fussy since vaccines given yesterday.  Slept well last night.  Fussy again today after emesis times 2 and small spit-ups.  For 1 hour period today had symmetic myoclonic movements of arms and legs, as well as head.
Approx 5 min /p vax, pt began to sneeze continuously, red watery eyes & clear mucus d/c from nose. Pt c/o difficulty breathing. Eprinephrine .4 cc adm SQ in lt arm. Pt remained in clinic approx 1 hr /wout further problems. MD called in RX
positive COVID-19 rapid test with symptoms; positive COVID-19 rapid test with symptoms; headache; nasal congestion; This is a spontaneous report from a contactable physician. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced positive COVID-19 rapid test with symptoms, headache and nasal congestion on an unspecified date. The patient developed headache and nasal congestion by the third day after the vaccination. The patient underwent lab tests and procedures which included COVID-19 rapid test: positive on an unspecified date. The clinical outcome of positive COVID-19 rapid test with symptoms, headache and nasal congestion was unknown.  The batch/lot number for the vaccine, BNT162B2, was not provided and has been requested during follow up.; Sender's Comments: The reported positive COVID-19 rapid test with symptoms after COVID-19 immunization is considered ineffective of BNT162B2, and the Company cannot completely exclude the possible causality between the reported event and BNT162B2 administration.
Body ache; Sore injection site; Swollen lymph nodes; Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body ache), VACCINATION SITE PAIN (Sore injection site), LYMPHADENOPATHY (Swollen lymph nodes), PYREXIA (Fever) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (Intramuscular use) 1 dosage form. On an unknown date, the patient experienced PAIN (Body ache), VACCINATION SITE PAIN (Sore injection site), LYMPHADENOPATHY (Swollen lymph nodes), PYREXIA (Fever) and HEADACHE (Headache). At the time of the report, PAIN (Body ache), VACCINATION SITE PAIN (Sore injection site), LYMPHADENOPATHY (Swollen lymph nodes), PYREXIA (Fever) and HEADACHE (Headache) had resolved.            Concomitant and treatment medications were not reported.  The patient had sore injection site, slightly swollen lymph nodes under the arm used for injection, fever (for 2 days), body ache, headache. It was unknown if the patient experienced any additional symptoms or events.   Reporter did not allow further contact
Within 2 minutes of vaccine developed dizziness, nausea, within 5 minutes developed mild tingling in her throat, felt cold and chest felt heavy. Lungs clear to auscultation, no rashes, no lip swelling. She received Benadryl 50 mg po at approx. 5-10 min post vaccine and was transferred to the ED. In the ED she had receive epinephrine im, Solumedrol iv and albuterol neb. Patient is still in the ED at 12:18 PM
Additional information was received on 7/15/02 from the physician regarding infant's medical history. A physician reported that a 4 month old male received his second dose of Prevnar on 2/25/02. The infant had a medical history of three episodes of acute otitis media. On 5/28/02, at age 7 months, he developed pneumococcal bacteremia and pneumonia. On 6/2/02, a blood culture was performed; Streptococcus pneumoniae serotype 14 was isloated. He was hospitalized that day. He had a good outcome and was discharged on 6/5/02. At the date of this report, no further information was available.
A report has been received from a Pharmacist concerning a 59 year old, male subject, who had been receiving FLUMIST. FLUMIST started on 25-Sep-2013. Pharmacist reported that they had one staff member who received FLUMIST who was over 50 years of age on 25-Sep-2013. The outcome of the event of administration to a person over 50 years of age is unknown. The report was considered to be non-serious.